biotech
EMEA Approves First Therapeutic Produced in Transgenic Goat
Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture , Genomics, Proteomics and Bioinformatics by ruth on June 7, 2006
EMEA Approves First Therapeutic Produced in Transgenic Goat
Following a re-examination, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval for GTC Biotherapeutics' ATryn, a recombinant anti-clotting agent produced in the milk of genetically engineered goats. The CHMP recommended its use as prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency.
Upon approval, ATryn® will be the first antithrombin product approved for use in all 25 countries of the European Union. ATryn® will also be the only available antithrombin product that is produced by recombinant biotechnology and is not derived from the human blood supply.

This is an important milestone, marking the approval of the first recombinant drug produced in a transgenic animal. More details from GTC Biotherapeutics' press release.

Permalink: EMEA Approves First Therapeutic Produced in Transgenic Goat
Tags: transgenic  thrombosis  biotech  produced  goat  produced+transgenic  transgenic+goat  therapeutic+produced 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/23721
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for EMEA Approves First Therapeutic Produced in Transgenic Goat:

  • Currently 7.75/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.75 out of 4 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!